Rhythm Pharmaceuticals Announces New Employment Inducement Grants [Yahoo! Finance]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $80.00 to $79.00. They now have a "buy" rating on the stock.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $49.00.